View Older Stories View More Recent Stories
-
Roth Capital Remains Bullish Following Exar Corp. (EXAR) 4Q15 Results
-
Cytokinetics (CYTK) Clarifies Two Key Studies at R&D Event; Roth Affirms at 'Buy'
-
Roth Capital Says Consolidated Water Co (CWCO) Q1 Results Were 'Better than Meets the Eye'
-
NV5 Holdings (NVEE) Executing Well, Roth Capital Says; PT to $26
-
HII Technologies, Inc. Announces $3.05 Million Private Placement With Institutional and Accredited Investors
-
DepoMed (DEPO) Sell-Off an 'Over-Reaction', Roth Capital Says; PT to $28.50
-
Roth Capital Sidelined on Plug Power (PLUG) Until Path Towards Profitability Clears
-
New Products, Growing Distributor Base Remain Key for Revolution Lighting (RVLT) - Roth Capital
-
Nuverra Environmental (NES) is Stabilizing Business as E&P Activity Ebbs; Roth Boosts PT to $4
-
Roth Capital Lowers PT on LivePerson (LPSN) Following the Loss of AT&T
-
Roth Capital lowers PT Despite Manitex Int'l's (MNTX) Revenue Beat
-
Roth Capital Reiterates Buy For Applied Genetic Technologies (AGTC) Following Q3
-
Rexahn (RNN) Valuation Remains Compelling at Supinoxin, RX-3117 Phase 1 Milestones Near - Roth Capital
-
Roth Remains Positive on Daqo New Energy (DQ); Poly ASPs Can Remain at Current Levels for Only so Long
-
Streetinsider.com's Hot Lunchtime Reads 5/11: (LGND) (AAPL) (RL) (JPM) (OIL)
-
Ligand Pharma (LGND) PT Lifted to $127 at Roth Capital Following Q1 and as Pipeline Expands
-
Rexahn Pharmaceuticals Reports First Quarter 2015 Financial Results and Pipeline Update
-
Revolution Lighting Technologies Reports First Quarter 2015 Financial Results
-
SEC Compliance Featuring Products From Tauriga Sciences, Inc. at B. Riley & Co. Conference
-
Roth Capital Raises PT for Callon Petroleum (CPE) to $9.75 Following High Production in 1Q
-
Roth Capital Upgrades Hecla Mining (HL) to Buy
-
Roth Boosts PT on Concert Pharma (CNCE) to $22 Following; Deuterium Platform, Partnerships Will Bolster Gains
-
Winona Capital Invests In Diono® To Fuel Growth And Innovation
-
Roth Capital Reit Buy Following TearLab's (TEAR) 1Q Results
-
Roth Capital Assumes Power Solutions (PSIX) at Buy
-
SolarEdge Technologies (SEDG) Raises Guidance; Roth Capital Raises PT
-
Winona Capital Invests in Diono® to Fuel Growth and Innovation
-
Roth Capital Downgrades NVIDIA (NVDA) to Neutral
-
Roth Capital Partners Lowers PT on Planar Systems (PLNR) Anticipating 'Lull in Digital Signage'
-
Concerns Over Canadian Solar's (CSIQ) Q2 Outlook Likely 'Misplaced' - Roth Capital
-
Regeneron Pharma (REGN) PT Lifted to $490 at Roth Capital
-
ROTH Capital Partners Expands Technology with Addition of Brian Alger, CFA as a Senior Research Analyst In Technology
-
Roth Capital Upgrades SodaStream International (SODA) to Buy
-
Notable Analyst Rating Changes 5/6: (SRPT) (AXP) (YNDX) Upgraded; (NSM) (DEI) (FNFG) Downgraded
-
Pre-Open Stock Movers 05/06: (GEVA) (BRDR) (FATE) (MGI) Higher; (WLT) (ZU) (NDLS) Lower (more...)
-
Roth Capital Starts Digital Turbine (APPS) at Buy, PT $12
-
Roth Capital Upgrades GP Strategies (GPX) to Buy
-
Roth Capital Downgrades CorMedix (CRMD) to Neutral
-
Applied Genetic Tech (AGTC) Fundamentals Unchanged Amid NIH Publication on LCA w/ RPE65 Mutation
-
Roth Capital Upgrades Web.com Group (WWWW) to Buy
-
Cytori Therapeutics (CYTX) Prices Direct Offering at 77c/Unit
-
Cytori Prices Registered Direct Offering Providing for up to $25 million in Equity Financing
-
Roth Capital Downgrades PTC Therapeutics (PTCT) to Neutral
-
Roth Capital Starts Gaiam Inc. (GAIA) at Buy
-
Hannon Armstrong Sustainable Infrastructure Capital, Inc. Announces the Closing of its Public Offering of Common Stock
-
Roth Capital Starts Halcon Resources (HK) at Buy
-
Roth Capital Affirms BioLineRx (BLRX) at 'Buy' Following BL-8040 Update
-
Challenged Athletes Foundation to Celebrate Unbreakable Athletic Spirit at Ninth Annual Gala in New York City
-
Roth Capital Starts Marathon Patent Group (MARA) at Buy
-
Roth Nudges PT on Ballard Power (BLDP) up to $2.55; Recent Business Wins Set Topline Growth Trajectory

